Columnist Samuel Kirton attended the Pulmonary Fibrosis Foundation's Summit 2025, where the group's five-year strategic plan was unveiled.

Treatment with Endeavor Biomedicines’ experimental oral therapy ENV-101 (taladegib) improved lung function in people with IPF ...

This Veterans Day, columnist Samuel Kirton writes about the PACT Act, which expanded coverage for veterans exposed to toxic substances.

A Phase 2 trial testing experimental therapy CAL101 in people with IPF is recruiting participants. CAL101 has been granted ...

“Ready to get that tube out? Sam, are you ready to get that tube out? Are you in any pain? No. Are you ready to breathe on your own?” Those were among the first words I heard as my wife, Susan, sat at ...

Less than a year after my husband, Donnie, was diagnosed with pulmonary fibrosis, we decided to take a road trip to the suburbs of Denver to attend a memorial service for a close family friend. His ...

Blocking caspase-9 — an enzyme involved in programmed cell death, or apoptosis — may halt or reverse tissue scarring in pulmonary fibrosis (PF), according to a new preclinical study. Researchers found ...

Water is essential to life. As UC Davis Health notes, it’s “vital to our health. It plays a key role in many of our body’s functions, including bringing nutrients to cells, getting rid of wastes, ...

Software that uses artificial intelligence to analyze medical imaging tests may help facilitate earlier diagnosis and more accurate monitoring of pulmonary fibrosis in people with underlying lung ...

For the first time in more than 10 years, idiopathic pulmonary fibrosis (IPF) care teams and patients will have a new treatment option following the Oct. 7 approval of Jascayd (nerandomilast) by the U ...